Status:
COMPLETED
Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis
Lead Sponsor:
University of Arkansas
Collaborating Sponsors:
Arkansas Children's Hospital Research Institute
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
7-17 years
Brief Summary
The purpose of this study is to find out whether measurement of body composition has a prognostic value on clinical and overall outcome in pediatric patients with cystic fibrosis.
Detailed Description
Cystic fibrosis (CF) is one of the most common life-threatening inherited disorders affecting 1/35000 individuals in the US. In the past decades, the median predicted survival of CF patients has incre...
Eligibility Criteria
Inclusion
- Subjects who already have a diagnosis of CF based on universal diagnostic criteria
- Age 7 to 17 years at the time of enrollment
- Under routine medical control at the CF center of Arkansas Children's Hospital(ACH)
- Clinically stable in CF symptoms as determined by investigators
Exclusion
- Unstable current diagnosis of metabolic diseases including liver (cirrhosis) or renal disease
- Failure to give informed consent
- Individuals with pacemakers
- Pregnancy in females of childbearing age. A pregnancy test will be performed on females who are post-menarche before performing a DEXA scan
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01401439
Start Date
June 1 2012
End Date
July 1 2016
Last Update
August 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202